<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药合作投融资联盟 | wechat-feeds</title><link>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</link><description>医药行业</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 06 Apr 2021 10:12:14 +0800</pubDate><image><url>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</url><title>医药合作投融资联盟 | wechat-feeds</title><link>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>重磅！Sorrento宣布和艾森生物达成合并协议，总额可达4.88亿美元</title><link>https://mp.weixin.qq.com/s/XUOKMKHHOlNjczm5s9lcXw</link><description></description><content:encoded><![CDATA[重磅！Sorrento宣布和艾森生物达成合并协议，总额可达4.88亿美元]]></content:encoded><pubDate>Tue, 06 Apr 2021 10:06:49 +0800</pubDate></item><item><title>OncoResponse完成4060万美元C轮融资</title><link>https://mp.weixin.qq.com/s/nd4dAwZkbNkDbFUsvWm0kw</link><description></description><content:encoded><![CDATA[OncoResponse完成4060万美元C轮融资]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>BD交易|AffaMed Therapeutics与SIFI宣布成立合资公司</title><link>https://mp.weixin.qq.com/s/Sv6e-LyrhgjGBK93l6I9Zg</link><description></description><content:encoded><![CDATA[BD交易|AffaMed Therapeutics与SIFI宣布成立合资公司]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>Entrada Therapeutics完成1.16亿美元B轮融资</title><link>https://mp.weixin.qq.com/s/FJXuJi_8FYKKi7nDeee4_g</link><description></description><content:encoded><![CDATA[Entrada Therapeutics完成1.16亿美元B轮融资]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>新锐|1亿美元B轮融资，开发突破性遗传医学的CRISPR平台和管线</title><link>https://mp.weixin.qq.com/s/KBCc59ZfAXQiwDt_BI38Dw</link><description></description><content:encoded><![CDATA[新锐|1亿美元B轮融资，开发突破性遗传医学的CRISPR平台和管线]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>CirrusMD完成2000万美元C轮融资</title><link>https://mp.weixin.qq.com/s/PI5_ABJUIAixOf37k685YA</link><description></description><content:encoded><![CDATA[CirrusMD完成2000万美元C轮融资]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>前默沙东高管加入Flagship Pioneering孵化的AI新锐公司担任CEO</title><link>https://mp.weixin.qq.com/s/G6ffgUYEqawMes7nXsen7A</link><description></description><content:encoded><![CDATA[前默沙东高管加入Flagship Pioneering孵化的AI新锐公司担任CEO]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>B轮融资1.06亿美元，SNÅP平台开发针对肿瘤获得性耐药的新型疗法</title><link>https://mp.weixin.qq.com/s/bRg_e7r6Ripz6diQCzbP1w</link><description></description><content:encoded><![CDATA[B轮融资1.06亿美元，SNÅP平台开发针对肿瘤获得性耐药的新型疗法]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>新锐！CD46抗体偶联新药（ADC）公司完成4000万美元A轮融资</title><link>https://mp.weixin.qq.com/s/qMz_K2YImz2zn9AtOl6LxQ</link><description></description><content:encoded><![CDATA[新锐！CD46抗体偶联新药（ADC）公司完成4000万美元A轮融资]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>ADC平台公司Pyxis Oncology完成1.52亿美元B轮融资</title><link>https://mp.weixin.qq.com/s/q5KbBu7-WJigJtPQrN0fJA</link><description></description><content:encoded><![CDATA[ADC平台公司Pyxis Oncology完成1.52亿美元B轮融资]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>Flagship孵化的Omega Therapeutics完成1.26亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/jlfxRSwqYa4dbZ9roNhhLg</link><description></description><content:encoded><![CDATA[Flagship孵化的Omega Therapeutics完成1.26亿美元C轮融资]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>AffaMed Therapeutics完成1.7亿美元B轮融资，清池资本领投！</title><link>https://mp.weixin.qq.com/s/jyXswhay5NQIPF1f2dEYQg</link><description></description><content:encoded><![CDATA[AffaMed Therapeutics完成1.7亿美元B轮融资，清池资本领投！]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>Immune-Onc完成7300万美元B1/B2轮融资，海松资本领投！</title><link>https://mp.weixin.qq.com/s/I8jZpPdm3V6_8oAOHHvZRw</link><description></description><content:encoded><![CDATA[Immune-Onc完成7300万美元B1/B2轮融资，海松资本领投！]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>Bond Biosciences完成500万美元A轮融资</title><link>https://mp.weixin.qq.com/s/n8Szby6kbEBg6-2cXkiUAQ</link><description></description><content:encoded><![CDATA[Bond Biosciences完成500万美元A轮融资]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>数字医疗BrightInsight完成1.01亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/JPDfD6Hjj9oiI82NJ3lv3g</link><description></description><content:encoded><![CDATA[数字医疗BrightInsight完成1.01亿美元C轮融资]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>安进超7亿美元收购Rodeo Therapeutics，获得15-PGDH抑制剂</title><link>https://mp.weixin.qq.com/s/q6fhgHmhwKXgrVuyqfZhdw</link><description></description><content:encoded><![CDATA[安进超7亿美元收购Rodeo Therapeutics，获得15-PGDH抑制剂]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>Anwita获君实生物等超1800万美元B轮投资</title><link>https://mp.weixin.qq.com/s/cdZOifvG1ymWRph8No_LsQ</link><description></description><content:encoded><![CDATA[Anwita获君实生物等超1800万美元B轮投资]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>超57亿元！泰格医药5.2亿元做5只新基金LP，持续布局投资驱动业务增长！</title><link>https://mp.weixin.qq.com/s/VgeBCIS8pMVKL5Ww-9nDUA</link><description></description><content:encoded><![CDATA[超57亿元！泰格医药5.2亿元做5只新基金LP，持续布局投资驱动业务增长！]]></content:encoded><pubDate>Tue, 30 Mar 2021 10:03:31 +0800</pubDate></item><item><title>歌礼加强肿瘤布局，两款口服小分子PD-L1抑制剂披露</title><link>https://mp.weixin.qq.com/s/yJWEHBoXtR2jmTGxEuarrQ</link><description></description><content:encoded><![CDATA[歌礼加强肿瘤布局，两款口服小分子PD-L1抑制剂披露]]></content:encoded><pubDate>Tue, 30 Mar 2021 10:03:31 +0800</pubDate></item><item><title>重磅！联拓生物2亿美元引进一款眼科新药大中华区权益！</title><link>https://mp.weixin.qq.com/s/H3EcXLCO15IHz7kMs025Pw</link><description></description><content:encoded><![CDATA[重磅！联拓生物2亿美元引进一款眼科新药大中华区权益！]]></content:encoded><pubDate>Tue, 30 Mar 2021 10:03:31 +0800</pubDate></item></channel></rss>